WST
Status-Quo-PlayerWest Pharmaceutical Services
$259.96
+1.36%
as of 13 Apr
Power Core
Power Core in one sentence: West's moat is the regulatory co-dependency between its engineered elastomeric components and the drug products they contain, making supplier substitution a regulatory event rather than a procurement decision.
Direction of Movement
Navigating Post-Pandemic Normalization Toward Structural Growth
ROC 200
+13.6%
WST
West Pharmaceutical Services
$259.96
+1.36%
as of 13 Apr
DCF Fair Value: $100.68
Market data unavailable
Company Profile
West Pharmaceutical Services, Inc. is a global leader in designing and manufacturing drug packaging and delivery solutions for pharmaceutical, biotechnology, and medical device industries. The company specializes in elastomeric and polymer components that maintain the integrity and safety of injectable medicines, including vial stoppers, syringe plungers, cartridge-based delivery systems, and complete safety-engineered administration devices. Its product portfolio encompasses containment and delivery platforms supporting traditional small-molecule injectables and advanced biologics, along with prefillable syringe systems, custom-engineered polymer components, and integrated safety systems to reduce needlestick injuries and improve patient compliance. West Pharmaceutical Services, Inc. also offers design, testing, and regulatory support to assist customers in accelerating development timelines while meeting global quality standards. Operating through Proprietary Products and Contract-Manufactured Products segments, it manufactures pharmaceuticals, biologics, vaccines, and consumer healthcare products. Founded in 1923 and headquartered in Exton, Pennsylvania, the company maintains manufacturing facilities, R&D centers, and technical service laboratories across North America, Europe, and Asia-Pacific, fostering collaboration with leading drug firms worldwide.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,800
Website
https://www.westpharma.com